Analysis of human T-cell antigen receptor variable β gene usage following vaccination with recombinant HBsAg

Digestive Diseases and Sciences

Volumn 43, Issue 4, 1998, Pages 880-886

  Yuh, Kouichi ^a   Sugyo, Shinya ^b   Nakamura, Ken ^b   Shijo, Hiroshi ^b   Emi, Kanako ^b   Harada, Kyoko ^b   Yoshitake, Saeko ^b   Kimura, Nobuhiro ^b   Moribe, Toyoki ^b   Kaneshige, Toshihiko ^b   Okumura, Makoto ^b  

^a FUKUOKA UNIVERSITY   (Japan)

^b NONE

Author keywords

Cellular immune response; Hepatitis B virus; T cell antigen receptor; Vaccination

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HLA ANTIGEN CLASS 2; RECOMBINANT HEPATITIS B SURFACE ANTIGEN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE; VACCINATION;

ADULT; FEMALE; GENES, T-CELL RECEPTOR BETA; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; T-LYMPHOCYTES; VACCINATION;

EID: 14444279640     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018846921408     Document Type: Article

References (44)

1. McIntyre B, Allison JP: The mouse T-cell receptor: Structural heterogeneity of molecules of normal T cells defined by xenoantiserum. Cell 34:739-746, 1983
2. Meuer SC, Fitzgerald KA, Hussey RE, Hodgdon JC, Schlossman SF, Reinherz EL: Clonotypic structures involved in antigen-specific human T-cell function. J Exp Med 157:705-719, 1983
3. Ben-Nun A, Liblau RS, Cohen L, Lehmann D, Tournier-Lasserve E, Rosenzweig A, Jingwu Z, Raus JCM, Bach MA: Restricted T-cell receptor V beta usage by myelin basic protein-specific T-cell clones in multiple sclerosis: Predominant genes vary in individuals. Proc Natl Acad Sci USA 88:2466-2470, 1991
4. Dalgleish AG, Wilson S, Gompels M, Ludlam C, Gazzard B, Coates AM, Habeshaw J: T-cell receptor variable gene products and early HIV-1 infection. Lancet 339:824-828, 1992
5. Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D, Lotteau V, Scott-Algara D: Evidence for a viral superantigen in humans. Nature 358:507-510, 1992
6. Fink PJ, Matis LA, McElligott DL, Bookman M, Hedrick SM: Correlations between T-cell specificity and the structure of the antigen receptor. Nature 321:219-226, 1986
7. Nakamura K, Yuh K, Sugyo S, Shijo H, Kimura N, Okumura M: Apoptosis observed in peripheral T lymphocytes from patients with chronic hepatitis B. Gastroenterology 111:156-164, 1996
8. Dudley FJ, Fox RA, Sherlock S: Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet 1:723-726, 1972
9. Millich DR: Immune response to hepatitis B virus proteins: Relevance of the murine model. Semin Liver Dis 11:93-112, 1991
10. Margolis HS: Prevention of acute and chronic liver disease through immunization: Hepatitis B and beyond. J Infect Dis 168:9-14, 1993
11. Kaneshige T, Hashimoto M, Matsumoto Y, Kinoshita T, Hirasawa T, Uchida K, Inoko H: Serologic and nucleotide sequencing analysis of a novel DR52 associated DRB1 allele with the DR "NJ25" specificity, designated DRB1*1307. Hum Immunol 41:151-159, 1994
12. Maeda M, Maruyama N, Ishii H, Uryu N, Ota M, Tsuji K, Inoko H: A simple and rapid method for HLA-DQA1 genotyping by digestion of PCR-amplified DNA with allele-specific restriction endonucleases. Tissue Antigens 34:290-298, 1989
13. Sengar DPS, Goldstein R: Comprehensive typing of DQB1 alleles by PCR-RFLP. Tissue Antigens 43:242-248, 1994
14. Fukumori Y, Nagao N, Ohnoki S, Shibata H, Okubo Y, Yamaguchi H: A polymerase chain reaction-restriction fragment length polymorphism method with allele-specific primers for HLA-DPB1 genotyping. In HLA 1991, Vol 2. K Tsuji, M Aikawa, T Sasazuki (eds). Oxford, Oxford Science Publications, 1992, pp 331-333
15. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GMT, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA systems. Tissue Antigens 46:1-18, 1995
16. Wysocki LJ, Sato VL: "Panning" for lymphocytes: A method for cell selection. Proc Natl Acad Sci USA 75:2844-2848, 1978
17. Miyanohara A, Toh-e A, Nozaki C, Hamada F, Ohtomo N, Matsubara K: Expression of hepatitis B surface antigen in yeast. Proc Natl Acad Sci USA 80:1-5, 1983
18. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
19. Kimura N, Toyonaga B, Yoshikai Y, Du RP, Mak TW: Sequences and repertoire of the human T-cell receptor α and β chain variable region genes in thymocytes. Eur J Immunol 17:375-383, 1987
20. Kimura N, Toyonaga B, Yoshikai Y, Triebel F, Debre P, Minden MD, Mak TW: Sequences and diversity of human T cell receptor β chain variable region genes. J Exp Med 164:739-750, 1986
21. Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J: Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci USA 86:8941-8945, 1989
22. Sambrook J, Fritsch EF, Maniatis T: Analysis and cloning of eukaryotic genomic DNA. In Molecular cloning, Vol 2, 2nd ed. C Nolan (ed). New York, Cold Spring Harbor Press, 1989, pp 9-58
23. Dong RP, Kimura A, Numano F, Nishimura Y, Sasazuki T: HLA-linked susceptibility and resistance to Takayasu arteritis. Heart Vessels 7(suppl):73-80, 1992
24. Dong RP, Kimura A, Hashimoto H, Akizuki M, Nishimura Y, Sasazuki T: Difference in HLA-linked genetic background between mixed connective tissue disease and systemic lupus erythematosus. Tissue Antigens 41:20-25, 1993
25. Woolf B: On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253, 1955
26. Murillo LA, Tenjo FA, Clavijo OP, Orozco MA, Sampaio S, Kalil J, Patarroyo ME: A specific T-cell receptor genotype preference in the immune response to a synthetic Plasmodium falciparum malaria vaccine. Parasite Immunol 14:87-94, 1992
27. Hibberd ML, Wong FS, Nicholson LB, Demaine AG: Analysis of human T-cell receptor Vβ gene usage following immunization to tetanus toxoid in vivo. Immunology 79:398-402, 1993
28. Goudeau A, Denis F, Mounier M, Dubois F, Klein J, Godefroy A, Ballet M, Mountij A: Comparative multicentre study of the immunogenicity of different hepatitis B vaccines in healthy volunteers. Postgrad Med J 63(suppl 2):125-128, 1987
29. Ferrari C, Bertoletti A, Penna A, Cavalli A, Valli A, Missale G, Pilli M, Fowler P, Giuberti T, Chisari FV, Fiaccadori F: Identification of immunodominant T-cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest 88:214-222, 1991
30. Germain RN: The second class story. Nature 353:605-606. 1991
31. Barbey C, Watts C, Corradin G: Antigen-processing organelles from DRB1*1101 and DRB1*1104 B cell lines display a differential degradation activity*. Eur J Immunol 25:30-36, 1995
32. Clothia C, Boswell DR, Lesk AM: The outline structure of the T-cell αβ receptor. EMBO J 7:3745-3755, 1998
33. Kayser C, Waase I, Weyand CM, Goronzy JJ: T-cell receptor germline gene segments and HLA haplotypes control the length of the CDR3 of human T-cell receptor β chains. Cell Immunol 168:235-242, 1996
34. Russell JH, White CL, Loh DY: Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc Natl Acad Sci USA 88:2151-2155, 1991
35. Ucker DS, Meyers J, Obermiller PS: Activation-driven T-cell death. 2. Quantitative differences alone distinguish stimuli triggering nontransformed T-cell proliferation or death. J Immunol 144:1583-1592, 1992
36. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lympho-proliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:964-976, 1994
37. Owen-Schaub LB, Yonehara S, Crump WL III, Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 140:197-205, 1992
38. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S: Expression of Fas ligand in cells of T cell lineage. J Immunol 154:3806-3813, 1995
39. Nagata S, Goldstein P: The Fas death factor. Science 267:1449-1456, 1995
40. Ferrari C, Penna A, Giuberti T, Tong MJ, Ribera E, Fiaccadori F, Chisari FV: Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol 139:2050-2058, 1987
41. Casini A, Alberti A, Banchetti E, Schiavon E, Patussi V, Pontisso P, Surrenti C, Realdi G: Cell-mediated immunity to HBcAg in chronic HBV infection. Am J Clin Pathol 88:494-498, 1987
42. Tsai SL, Chen PJ, Lai MY, Yang PM, Sung JL, Huang JH, Hwang LH, Chang TH, Chen DS: Acute exacerbations of chronic type B hepatitis are accompanied by increased T-cell responses to hepatitis B core and e antigens. J Clin Invest 89:87-96, 1992
43. Cassani F, Valentini P, Cataleta M, Manotti P, Francesconi R, Giostra F, Bianchi FB: Ultrasound-detected deep abdominal lymph nodes in chronic hepatitis C: High frequency and relationship with viremia. J Hepatol 23(suppl 1):143, 1995 (abstract)
44. Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B, Kaiser R, Sauerbruch T, Spengler U: T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia. Hepatology 24:790-795, 1996